Follow this preprint
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients
Lars E. Hillege, View ORCID ProfileKai R. Trepka, Janine Ziemons, Romy Aarnoutse, Benjamin G. H. Guthrie, Judith de Vos-Geelen, Liselot Valkenburg-van Iersel, Irene E.G. van Hellemond, Arnold Baars, Johanna H.M.J. Vestjens, John Penders, Adam Deutschbauer, Chloe E. Atreya, Wesley A. Kidder, View ORCID ProfilePeter J. Turnbaugh, Marjolein L. Smidt
doi: https://doi.org/10.1101/2024.10.11.24315249
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Lars E. Hillege
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
2Department of Surgery, Maastricht University Medical Center+; Maastricht, Netherlands
Kai R. Trepka
3Department of Microbiology and Immunology, University of California San Francisco; San Francisco, USA
Janine Ziemons
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
2Department of Surgery, Maastricht University Medical Center+; Maastricht, Netherlands
Romy Aarnoutse
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
2Department of Surgery, Maastricht University Medical Center+; Maastricht, Netherlands
Benjamin G. H. Guthrie
3Department of Microbiology and Immunology, University of California San Francisco; San Francisco, USA
Judith de Vos-Geelen
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
4Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center+; Maastricht, The Netherlands
Liselot Valkenburg-van Iersel
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
4Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center+; Maastricht, The Netherlands
Irene E.G. van Hellemond
5Department of Medical Oncology, Catharina Hospital; Eindhoven, The Netherlands
Arnold Baars
6Department of Medical Oncology, Hospital Gelderse Vallei; Ede, The Netherlands
Johanna H.M.J. Vestjens
7Department of Internal Medicine, VieCuri Medical Center; Venlo, The Netherlands
John Penders
8NUTRIM - Institute of Nutrition and Translational Research in Metabolism, Maastricht University; Maastricht, The Netherlands
9Department of Medical Microbiology, Infectious Diseases, and Infection Prevention, Maastricht University Medical Center+; Maastricht, The Netherlands
Adam Deutschbauer
10Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory; Berkeley, USA
Chloe E. Atreya
11Department of Medicine, Division of Hematology and Oncology, University of California San Francisco; San Francisco, USA
12UCSF Helen Diller Family Comprehensive Cancer Center; San Francisco, USA
Wesley A. Kidder
11Department of Medicine, Division of Hematology and Oncology, University of California San Francisco; San Francisco, USA
12UCSF Helen Diller Family Comprehensive Cancer Center; San Francisco, USA
Peter J. Turnbaugh
3Department of Microbiology and Immunology, University of California San Francisco; San Francisco, USA
13Chan Zuckerberg Biohub-San Francisco; San Francisco, USA
Marjolein L. Smidt
1GROW - Research Institute for Oncology and Reproduction, Maastricht University; Maastricht, Netherlands
2Department of Surgery, Maastricht University Medical Center+; Maastricht, Netherlands

Data Availability
All raw sequencing data with human reads removed have been deposited to the NCBI Sequence Read Archive (SRA) and are accessible via BioProject PRJNA1169175. Processed datasets and all original code used in this study is available on GitHub (https://github.com/turnbaughlab/2024_Trepka_DrugToxicity).
Posted October 15, 2024.
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients
Lars E. Hillege, Kai R. Trepka, Janine Ziemons, Romy Aarnoutse, Benjamin G. H. Guthrie, Judith de Vos-Geelen, Liselot Valkenburg-van Iersel, Irene E.G. van Hellemond, Arnold Baars, Johanna H.M.J. Vestjens, John Penders, Adam Deutschbauer, Chloe E. Atreya, Wesley A. Kidder, Peter J. Turnbaugh, Marjolein L. Smidt
medRxiv 2024.10.11.24315249; doi: https://doi.org/10.1101/2024.10.11.24315249
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3204)
- Dermatology (270)
- Emergency Medicine (475)
- Epidemiology (13203)
- Forensic Medicine (19)
- Gastroenterology (885)
- Genetic and Genomic Medicine (5032)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3166)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4778)
- Nursing (253)
- Nutrition (707)
- Oncology (2460)
- Ophthalmology (698)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1272)
- Primary Care Research (545)
- Public and Global Health (7340)
- Radiology and Imaging (1660)
- Respiratory Medicine (961)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (198)